TARPLIN, DOWNS & YOUNG, LLC for GENENTECH, INC.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
H.R. 5376, the Inflation Reduction Act prescription drug access and affordability, coding, coverage, value based payments, biosimilars, Part B, Part D, innovation, combination products, 340B, international reference pricing, CMMI
| Lobbyist | Covered position, as disclosed |
|---|---|
| KIMBERLY LYNN BRANDT | Sr. Counsel and Dir. External Affairs - HHS OIG; Prin. Dep. Administrator for Policy and Operations and Dir. of Medicare Program Integrity - CMS; Chief Oversight and General Counsel - Senate Cmte. on Finance |
| RAISSA H DOWNS | Prin. Dep. Asst. Sec. for Leg. - HHS; Dep. Asst. Sec. for Leg. - HHS; Staff Dir., Sub. Cmte. on Employment, Sen. HELP Cmte. |
| MICHELLE P EASTON | Chief Health Counsel, Sen. Cmte. on Finance; Staff Dir., Senate Aging Cmte.; Leg. Asst., Congressman Billy Tauzin |
| CHARLOTTE SPEARS IVANCIC | Leg. Counsel, Sen. Jim DeMint; Health Counsel, Maj. Leader Bill Frist; Counsel and Budget Analyst, House Budget Cmte.; Asst. to the Speaker for Policy, Speaker John Boehner |
| ELIZABETH T MURRAY | Senior Policy Advisor, Democratic Whip Steny Hoyer; Legislative Asst. for Rep. Mike Thompson, Rep. Bob Matsui, and Senator Bob Graham |
| EMILY H MURRY | Staff Dir., Sub. Cmte. on Health, W&M Cmte; Sr. Policy Advisor, Majority Leader McCarthy; Policy Advisor, Majority Whip McCarthy; Professional Staff, Republican Study Cmte.; Leg. Aid, Rep. Ken Calvert; Leg. Asst., Rep. Tom Price |
| PAMELA SMITH | Leg. Dir., Sen. Tom Harkin; Dep. Staff Dir., Senate HELP Cmte; Staff Dir., Senate HELP Cmte; Counselor to the Asst. AG, Civil Div., Dept of Justice; Spec Counsel, Ofc of Leg. Affairs, Dept of Justice; Counsel and LA, Senator Carol Moseley-Braun |
| JENNIFER B YOUNG | Asst. Sec. for Leg. - HHS; Dep. Asst. Sec. for Leg. - HHS; Cmte. Staff, House Cmte. on Ways and Means; Cmte. Staff, Sen. Cmte. on Finance |
Health Issues HCR
H.R. 5376, the Inflation Reduction Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 drug pricing and access, transparency, covid, 340B, drug safety
| Lobbyist | Covered position, as disclosed |
|---|---|
| KIMBERLY LYNN BRANDT | — |
| RAISSA H DOWNS | — |
| MICHELLE P EASTON | — |
| CHARLOTTE SPEARS IVANCIC | — |
| ELIZABETH T MURRAY | — |
| EMILY H MURRY | — |
| PAMELA SMITH | — |
| JENNIFER B YOUNG | — |
Budget/Appropriations BUD
H.R. 5376, the Inflation Reduction Act H.R. 6833, Continuing Appropriations and Ukraine Supplemental Appropriations Act of 2023
| Lobbyist | Covered position, as disclosed |
|---|---|
| KIMBERLY LYNN BRANDT | — |
| RAISSA H DOWNS | — |
| MICHELLE P EASTON | — |
| CHARLOTTE SPEARS IVANCIC | — |
| ELIZABETH T MURRAY | — |
| EMILY H MURRY | — |
| PAMELA SMITH | — |
| JENNIFER B YOUNG | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.